Daniela S. Bundschuh

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

Leonardo M. Fabbri, Peter M.A. Calverley, José Luís Izquierdo Alonso et al. · The Lancet · 2009 · 611 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor

Daniela S. Bundschuh, Manfrid Eltze, Johannes Barsig et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 239 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Improved Innate Immunity of Endotoxin-Tolerant Mice Increases Resistance to<i>Salmonella enterica</i>Serovar Typhimurium Infection despite Attenuated Cytokine Response

Martin D. Lehner, Josepha Ittner, Daniela S. Bundschuh et al. · Infection and Immunity · 2001 · 120 citations

Veterinary Medicine, Immunology, Microbiology +17

Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice

Daniela S. Bundschuh, Johannes Barsig, Thomas Härtung et al. · The Journal of Immunology · 1997 · 110 citations · Full text

Life Sciences, Immunology, Pharmacology +17

In Vitro and in Vivo Anti-Inflammatory Activity of the New Glucocorticoid Ciclesonide

Michael Stoeck, R. M. Riedel, Günther Hochhaus et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 107 citations

Medicine, Medicinal Chemistry, Pharmacology +17